Coegin Pharma AB (NGM:COEGIN)
Sweden · Delayed Price · Currency is SEK 3.720
-0.040 (-1.06%)
At close: May 29, 2026
Coegin Pharma AB Revenue
Coegin Pharma AB had revenue of 292.00K SEK in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 371.00K. In the year 2025, Coegin Pharma AB had annual revenue of 79.00K.
Revenue (ttm)
371.00K
Revenue Growth
n/a
P/S Ratio
286.68
Revenue / Employee
123.67K
Employees
3
Market Cap
106.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 79.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lohilo Foods AB | 198.07M |
| Spotlight Group AB | 114.43M |
| Aquaticus Real Estate AB | 52.90M |
| Mediacle Group AB | 47.49M |
| Amido AB | 43.62M |
| Ramlösa shipping AB | 39.45M |
| Railway Metrics and Dynamics Sweden AB | 13.62M |
| Abera Bioscience AB | 11.87M |
Coegin Pharma AB News
- 11 days ago - Coegin Pharma AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Coegin Pharma AB Quarterly report: Q4 2025 - Filings
- 3 months ago - Coegin Pharma AB Annual report: Q4 2025 - Filings
- 6 months ago - Coegin Pharma AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Coegin Pharma AB Quarterly report: Q2 2025 - Filings